$815,00M | |
$11,21 | |
$30,23 | |
$0,92 | |
$11,23 | |
$+0,23 | |
+2,05% | |
426K |
Omeros Corporation (OMER) is currently trading at $11,50 as of 2026-02-12 18:38:05, reflecting a +2,05% move ($+0,23) from the previous close.
In the short term, the stock has returned -1.211,77% over the past four weeks. Over the last 12 months, Omeros Corporation has recorded a +34,60% price change, indicating a strong performance relative to the broader market.
Over the past seven days, Omeros Corporation has traded within a short-term range shaped by market sentiment in the PHARMACEUTICAL PREPARATIONS sector. During this period, the stock moved from its previous closing price of $11,00 to the latest recorded price of $11,50, reflecting an intraday change of +2,05%. Daily movements highlight shifts in trading volume (426.201), investor positioning, and reactions to macroeconomic updates.
From a momentum standpoint, OMER has delivered a -1.211,77% return over the past month and a +34,60% change in the last 12 months, indicating a strong trend relative to its broader sector peers.
You can buy and trade OMER on MEXC in three simple steps:
Omeros Corp is a United States-based clinical-stage biopharmaceutical company engaged in discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders. The drug candidate in the pipeline of complement-targeted therapeutics is narsoplimab (OMS721), a proprietary, patented human monoclonal antibody targeting mannan-binding lectin-associated serine protease 2, the key activator of the lectin pathway of complement. Clinical development of narsoplimab is currently focused on hematopoietic stem cell transplant-associated thrombotic microangiopathy and immunoglobulin nephropathy.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 202 |
| Sector | PHARMACEUTICAL PREPARATIONS |
| Company Website |
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Amount
1 OMER = 11,495 USD